81317 Pms2 gene full seq analysis
Also known as: PMS2 full sequencing, Lynch syndrome genetic test
Post-Meiotic Segregation Increased 2 (PMS2) gene full gene sequence analysis to identify variants causing Lynch syndrome.
In Plain Language
Colorectal cancer predisposition test; Lynch syndrome screening
Clinical Context
Full PMS2 sequencing for Lynch syndrome diagnosis, particularly important as PMS2 mutations account for 5% of Lynch syndrome cases.
RVU Information
CPT 81317 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81317?
CPT 81317 (Pms2 gene full seq analysis) is a Pathology & Lab code. Post-Meiotic Segregation Increased 2 (PMS2) gene full gene sequence analysis to identify variants causing Lynch syndrome.
Who uses CPT code 81317?
CPT 81317 is used by Pathology, Oncology, Gastroenterology. Full PMS2 sequencing for Lynch syndrome diagnosis, particularly important as PMS2 mutations account for 5% of Lynch syndrome cases.
When is CPT 81317 used?
Full PMS2 sequencing for Lynch syndrome diagnosis, particularly important as PMS2 mutations account for 5% of Lynch syndrome cases.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.